Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Simulations Plus Inc (SLP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011937
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides preclinical and clinical pharmacometric consulting services to help its customers with regulatory submissions. Simulations Plus’s pharmaceutical and chemistry software is licensed to agrochemical, biotechnology, pharmaceutical and food industries, and regulatory agencies worldwide. The company offers training workshops and provides consulting services. Simulations Plus distributes its products and offers services in Australia, China, Europe, India, Japan, North America, New Zealand, South America, Singapore, and Taiwan. It operates along with its wholly owned subsidiary Cognigen Corporation. Simulations Plus is headquartered in Lancaster, California, the US.

Simulations Plus Inc (SLP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Simulations Plus Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Simulations Plus Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Simulations Plus Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Simulations Plus Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Simulations Plus Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Simulations Plus Inc, Medical Equipment, Deal Details 11
Partnerships 11
Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases 11
Simulations Plus Enters Into Agreement With Pharma Company 12
Acquisition 13
Prentke Romich Completes Acquisition Of Words+ From Simulations Plus For US$2 Million 13
Simulations Plus Inc – Key Competitors 15
Simulations Plus Inc – Key Employees 16
Simulations Plus Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 14, 2017: Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results 18
Oct 03, 2017: Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017 19
Jul 10, 2017: Simulations Plus Reports Third Quarter FY2017 Financial Results 20
Jun 15, 2017: Simulations Plus Reports Record Preliminary Revenues for Third Quarter FY2017 21
Apr 10, 2017: Simulations Plus Reports Second Quarter FY2017 Financial Results 22
Mar 13, 2017: Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2017 23
Jan 09, 2017: Simulations Plus Reports First Quarter FY2017 Financial Results 24
Dec 08, 2016: Simulations Plus Reports Record Preliminary Revenues for First Quarter FY2017 25
Nov 11, 2016: Simulations Plus Reports FY2016 and Fourth Quarter FY2016 Financial Results 26
Sep 12, 2016: Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2016 27
Jul 14, 2016: Simulations Plus Reports Third Quarter FY2016 Financial Results 28
Jun 07, 2016: Simulations Plus Reports Preliminary Revenues for Third Quarter FY2016 29
Apr 13, 2016: Simulations Plus Reports Second Quarter FY2016 Financial Results 30
Mar 10, 2016: Simulations Plus Reports Record Preliminary Revenues for Second Quarter FY2016 31
Jan 14, 2016: Simulations Plus Reports First Quarter FY2016 Financial Results 32
Corporate Communications 33
Aug 31, 2017: Simulations Plus Announces Senior Management Changes 33
Product News 34
Apr 05, 2017: Simulations Plus Releases GastroPlus Version 9.5 34
Jan 12, 2017: Simulations Plus Releases ADMET Predictor Version 8.1 35
Apr 14, 2016: Simulations Plus Releases DDDPlus Version 5.0 36
Mar 15, 2016: Simulations Plus Releases KIWI Version 1.5 37
Other Significant Developments 38
Aug 23, 2017: Simulations Plus Releases MembranePlus Version 2 38
Apr 20, 2017: Simulations Plus Establishes Distribution Channel in India with Electrolab 39
Apr 06, 2017: Simulations Plus Finalizes Distributor Agreement With Korean Company 40
Sep 26, 2016: Simulations Plus Joins European SimInhale Consortium 41
Apr 06, 2016: Simulations Plus Signs 5-year Consulting Agreement with Major Research Foundation 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Simulations Plus Inc, Medical Equipment, Key Facts, 2016 2
Simulations Plus Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Simulations Plus Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Simulations Plus Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Simulations Plus Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Simulations Plus Inc, Deals By Market, 2011 to YTD 2017 9
Simulations Plus Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Simulations Plus Enters Into Distribution Agreement With Research Institute for Liver Diseases 11
Simulations Plus Enters Into Agreement With Pharma Company 12
Prentke Romich Completes Acquisition Of Words+ From Simulations Plus For US$2 Million 13
Simulations Plus Inc, Key Competitors 15
Simulations Plus Inc, Key Employees 16
Simulations Plus Inc, Other Locations 17
Simulations Plus Inc, Subsidiaries 17

★海外企業調査レポート[Simulations Plus Inc (SLP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SK Bioland Co Ltd:企業の戦略・SWOT・財務情報
    SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report Summary SK Bioland Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Extraction Oil & Gas Inc (XOG):企業の財務・戦略的SWOT分析
    Extraction Oil & Gas Inc (XOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Serina Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Serina Therapeutics Inc (Serina Therapeutics) is a drug company that develops therapeutics for cancer, inflammation, pain, and metabolic disorders. The company’s pipeline product includes SER-214, SER-226, SER-228, SER-232, and other proprietary drugs. It uses proprietary technology, polyoxa …
  • Ferrovial, S.A.:企業の戦略・SWOT・財務分析
    Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report Summary Ferrovial, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pakistan State Oil Co Ltd (PSO):企業の財務・戦略的SWOT分析
    Pakistan State Oil Co Ltd (PSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Innergex Renewable Energy Inc (INE)-エネルギー分野:企業M&A・提携分析
    Summary Innergex Renewable Energy Inc. (Innergex) is an electricity services company that develops, owns, and operates renewable power-generating facilities. It sells electricity that is generated from hydro, wind, and solar sources. The company sells electricity through long-term power purchase agr …
  • Cascades Inc.:企業の戦略・SWOT・財務情報
    Cascades Inc. - Strategy, SWOT and Corporate Finance Report Summary Cascades Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Westminster Travel Limited:企業の戦略・SWOT・財務分析
    Westminster Travel Limited - Strategy, SWOT and Corporate Finance Report Summary Westminster Travel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • FGL Sports Ltd. :企業の戦略・SWOT・財務情報
    FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report Summary FGL Sports Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Goodman Group:企業のM&A・事業提携・投資動向
    Goodman Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goodman Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • University of Southampton-製薬・医療分野:企業M&A・提携分析
    Summary University of Southampton (UOS) is an educational institute that offers undergraduate and postgraduate programs. The university offers educational programs across various disciplines including accounting and finance, acoustical engineering, aeronautics and astronautics, anthropology, archaeo …
  • Racetrac Petroleum, Inc.
    Racetrac Petroleum, Inc. - Strategy, SWOT and Corporate Finance Report Summary Racetrac Petroleum, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fortune Electric Co Ltd (1519):企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company provides products such as distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It …
  • OncoTartis Inc-製薬・医療分野:企業M&A・提携分析
    Summary OncoTartis Inc (OncoTartis) is a biotechnology company with a focus on development of various treatments for various types of cancers. Its lead candidate OT-82, an orally available NicotinAMide Phosphoribosyl Transferase inhibitor, is being developed for treating broad range of leukemias and …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia Biosciences) is an agricultural and clean technology company that develops and commercializes agricultural products. The company's products exhibit traits include drought tolerance, stacked traits, herbicide tolerance, water use efficiency, nitrogen use effic …
  • Xcel Energy Inc (XEL):電力:M&Aディール及び事業提携情報
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Health Net Inc:企業の戦略的SWOT分析
    Health Net Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • MegaChips Corporation (6875):企業の財務・戦略的SWOT分析
    MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Immune Pharmaceuticals Inc (IMNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆